Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP)

21 filings reported holding COCP - Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share as of Q1 2023.
Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 738,638 shares of 13,831,528 outstanding shares and own 5.34% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (271,445 shares), RENAISSANCE TECHNOLOGIES LLC (119,828 shares), BlackRock Inc. (74,063 shares), GEODE CAPITAL MANAGEMENT, LLC (69,534 shares), SABBY MANAGEMENT, LLC (66,172 shares), MORGAN STANLEY (44,694 shares), STATE STREET CORP (24,443 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (20,728 shares), Parallel Advisors, LLC (15,228 shares), and NORTHERN TRUST CORP (12,207 shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.